ZA96885B - PT complexes - Google Patents

PT complexes

Info

Publication number
ZA96885B
ZA96885B ZA96885A ZA96885A ZA96885B ZA 96885 B ZA96885 B ZA 96885B ZA 96885 A ZA96885 A ZA 96885A ZA 96885 A ZA96885 A ZA 96885A ZA 96885 B ZA96885 B ZA 96885B
Authority
ZA
South Africa
Prior art keywords
carboxylate
hydroxy
different
halo
same
Prior art date
Application number
ZA96885A
Other languages
English (en)
Inventor
Barry Anthony Murrer
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Publication of ZA96885B publication Critical patent/ZA96885B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086Platinum compounds
    • C07F15/0093Platinum compounds without a metal-carbon linkage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Studio Devices (AREA)
ZA96885A 1995-02-14 1996-02-05 PT complexes ZA96885B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9502799.1A GB9502799D0 (en) 1995-02-14 1995-02-14 Improvements in platinum complexes

Publications (1)

Publication Number Publication Date
ZA96885B true ZA96885B (en) 1996-08-14

Family

ID=10769529

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96885A ZA96885B (en) 1995-02-14 1996-02-05 PT complexes

Country Status (19)

Country Link
US (2) US5665771A (de)
EP (1) EP0727430B1 (de)
JP (1) JP3219235B2 (de)
KR (1) KR100339866B1 (de)
AT (1) ATE202111T1 (de)
AU (1) AU707814B2 (de)
CA (1) CA2169019C (de)
DE (1) DE69613254T2 (de)
DK (1) DK0727430T3 (de)
ES (1) ES2157399T3 (de)
FI (1) FI120493B (de)
GB (1) GB9502799D0 (de)
GR (1) GR3036513T3 (de)
HK (1) HK1011997A1 (de)
NO (1) NO307569B1 (de)
NZ (1) NZ280946A (de)
PT (1) PT727430E (de)
TW (1) TW432068B (de)
ZA (1) ZA96885B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001872A (en) * 1999-03-05 1999-12-14 Virginia Commonwealth University Water soluble transplatinum complexes with anti-cancer activity and method of using same
US6413953B1 (en) * 1999-04-13 2002-07-02 Anormed Inc. Pt(IV) antitumor agent
IL145671A0 (en) * 1999-04-13 2002-06-30 Anormed Inc Process for preparing amine platinum complexes
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
AUPQ641100A0 (en) * 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
US6894049B1 (en) * 2000-10-04 2005-05-17 Anormed, Inc. Platinum complexes as antitumor agents
DE60235375D1 (de) 2001-08-23 2010-04-01 Yissum Res Dev Co Platinkomplexe und deren verwendung in der therapie
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168661B2 (en) * 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) * 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) * 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
WO2008097661A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
US20110033528A1 (en) * 2009-08-05 2011-02-10 Poniard Pharmaceuticals, Inc. Stabilized picoplatin oral dosage form
AU2008214199A1 (en) * 2007-02-09 2008-08-14 Poniard Pharmaceuticals, Inc. Encapsulated picoplatin
US20100260832A1 (en) * 2007-06-27 2010-10-14 Poniard Pharmaceuticals, Inc. Combination therapy for ovarian cancer
TW200916094A (en) * 2007-06-27 2009-04-16 Poniard Pharmaceuticals Inc Stabilized picoplatin dosage form
CN101809024A (zh) * 2007-07-16 2010-08-18 铂雅制药公司 吡铂的口服制剂
JP2011511071A (ja) * 2008-02-08 2011-04-07 ポニアード ファーマシューティカルズ, インコーポレイテッド 肺癌を治療するためのピコプラチンおよびアムルビシン
CN101775040B (zh) * 2009-12-31 2012-05-09 南京臣功制药有限公司 吡铂的制备方法
WO2015009841A2 (en) 2013-07-16 2015-01-22 Blend Therapeutics Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof
CN106943343B (zh) * 2016-01-06 2020-05-12 山东新时代药业有限公司 一种甲啶铂注射液及其制备方法
WO2017192290A1 (en) 2016-05-04 2017-11-09 The Wistar Institute Of Anatomy And Biology Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432562A (en) 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
KR840007599A (ko) * 1983-01-21 1984-12-08 마쓰바라 이찌로오 백금 착화합 유기물의 제조방법
US4533502A (en) * 1983-02-22 1985-08-06 Rochon Fernande D Platinum (II) compounds and their preparation
DE3582961D1 (de) * 1984-06-27 1991-07-04 Johnson Matthey Plc Platinkoordinationsverbindungen.
JPS61238795A (ja) * 1985-04-16 1986-10-24 エンゲルハード・コーポレーシヨン 白金トリアミン抗腫瘍剤
DE3777583D1 (de) * 1986-12-18 1992-04-23 Shionogi & Co Ammine-n-heterocyclische platinkomplexe und antitumormittel.
US4812193A (en) * 1986-12-22 1989-03-14 Gauron Richard F Inset panel fastener and method of using
ATE113054T1 (de) * 1988-02-02 1994-11-15 Johnson Matthey Inc Pt(iv) komplexe.
GB8806044D0 (en) * 1988-03-14 1988-04-13 Johnson Matthey Plc Platinum coordination compounds
GB9105037D0 (en) * 1991-03-09 1991-04-24 Johnson Matthey Plc Improvements in chemical compounds
US5624919A (en) * 1993-09-14 1997-04-29 The University Of Vermont And State Agricultural College Trans platinum (IV) complexes
GB9408218D0 (en) * 1994-04-26 1994-06-15 Johnson Matthey Plc Improvements in platinum complexes
IL145671A0 (en) * 1999-04-13 2002-06-30 Anormed Inc Process for preparing amine platinum complexes
DE60235375D1 (de) * 2001-08-23 2010-04-01 Yissum Res Dev Co Platinkomplexe und deren verwendung in der therapie
ATE514706T1 (de) * 2004-09-01 2011-07-15 Platco Technologies Proprietary Ltd Herstellung von platin (ii)-komplexen
WO2007021852A2 (en) * 2005-08-11 2007-02-22 Virginia Commonwealth University Transplatinum complexes with n2o2 donor sets as cytotoxic and antitumor agents

Also Published As

Publication number Publication date
EP0727430A1 (de) 1996-08-21
NO307569B1 (no) 2000-04-25
JPH08259581A (ja) 1996-10-08
HK1011997A1 (en) 1999-07-23
NO960569D0 (no) 1996-02-13
TW432068B (en) 2001-05-01
US5665771A (en) 1997-09-09
GB9502799D0 (en) 1995-04-05
PT727430E (pt) 2001-11-30
ES2157399T3 (es) 2001-08-16
CA2169019C (en) 2003-02-04
KR960030940A (ko) 1996-09-17
USRE41209E1 (en) 2010-04-06
DK0727430T3 (da) 2001-09-03
NO960569L (no) 1996-08-15
ATE202111T1 (de) 2001-06-15
FI120493B (fi) 2009-11-13
EP0727430B1 (de) 2001-06-13
FI960660A (fi) 1996-08-15
KR100339866B1 (ko) 2002-11-07
CA2169019A1 (en) 1996-08-15
GR3036513T3 (en) 2001-12-31
AU4225896A (en) 1996-08-22
DE69613254D1 (de) 2001-07-19
AU707814B2 (en) 1999-07-22
JP3219235B2 (ja) 2001-10-15
DE69613254T2 (de) 2001-09-20
FI960660A0 (fi) 1996-02-14
NZ280946A (en) 1997-05-26

Similar Documents

Publication Publication Date Title
ZA96885B (en) PT complexes
MY120235A (en) Aryloxyarylsulfonylamino hydroxamic acid derivatives
GR20010300028T1 (en) Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
ES8701707A1 (es) Procedimiento para preparar derivados del acido acrilico conactividad fungicida
AU1766195A (en) Improvements in platinum complexes
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
GEP20033140B (en) Substituted Bicyclic Derivatives Useful as Anticancer Agents
DK0952148T3 (da) Cyclobutylaryloxyarylsulfonylaminohydroxamsyrederivater
BR0211422A (pt) Processo para a preparação de um composto ou de um éster ou um sal do mesmo, e, composto
DE69533043D1 (de) Acrylamid-derivate und verfahren zu deren herstellung
TR200101474T2 (tr) Yeni ara maddeler, bunlardan makrolid antibiyotik aktif madde hazırlanması.
EP0255689A3 (en) Process for the preparation of 1-hydroxy-2-pyridinones
EP0647625A4 (de)
DE3678086D1 (de) Rhizoxinderivate, ihre herstellung und pharmazeutische verwendung.
DE68901024D1 (de) Gegen anaerobe bakterien wirksame antibiotika, ihre produktion und enterobakter-staemme, die sie produzieren.
GR3031709T3 (en) Octahydro-2-naphthalenecarboxylic acid derivative, its production and use.
DE69729114D1 (de) 1,3-diphenylphosphinopropan-liganden und entsprechende übergangsmetallkomplexe, deren herstellung und verwendung
TR199701744T1 (xx) Ha�arat m�cadele maddesi olarak s�bstit�e edilmi� 1,3-Dioksan-5-�lamino-Heterosayk�llar�.
TH19367A (th) ซับสทิทิวเทค 2-เฟนิล พิริดีน
ES8704891A1 (es) Procedimiento para la obtencion de n-halogenoalquilsulfenil-(tio)-carbamatos
TH29868A (th) วิธีการและองค์ประกอบของสารสำหรับทำให้สีของผิวหนังจางลง
EP1101819A4 (de) Any-rf gen, wachstumsrühe regulierende substanz, verfahren zu seiner herstellungund zellregulator fur lebende zellen
BG51718A1 (en) 1-aryl-3-furfuryl-carbamides,method for their preparation and their application